UAB "LEVIPHARM" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
2,540 |
2,540 |
957 |
-957 |
-957 |
-41.97 |
-37.68 |
5,077 |
540 |
0 |
5,617 |
2023 |
---|
4,230 |
4,230 |
1 |
-1 |
-1 |
34.54 |
-0.02 |
5,077 |
1,603 |
0 |
6,680 |
2024 |
---|
3,960 |
3,960 |
4,775 |
-4,775 |
-4,775 |
21.79 |
-120.58 |
341 |
883 |
0 |
1,224 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
3,960 €-6 % *
Sales per employee (€)
3,960 €-6 % *
Profit before tax (€)
4,775 €477,400 % *
Net Profit (€)
-4,775 €-477,400 % *
Profit per employee (€)
-4,775 €-477,400 % *
Total profitability (%)
21.79 %-36.91 % *
Net profitability (%)
-120.58 %-602,800.00 % *
Equity (€)
341 €-93 % *
Amounts Payable And Liabilities (€)
883 €-45 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
1,224 €-82 % *